A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus
NCT ID: NCT04214028
Last Updated: 2025-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2019-12-26
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation
NCT04189627
A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
NCT03067129
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
NCT03740230
Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)
NCT04903626
Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6
NCT03341871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Maviret Participants
Participants receiving glecaprevir plus pibrentasvir (GLE/PIB, other names: Maviret) as routine standard of care for HCV.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Enrolled after Maviret treatment begins
* Prior treatment with Maviret
Exclusion Criteria
12 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kariya Toyota General Hospital /ID# 239046
Kariya-shi, Aichi-ken, Japan
Meijo Hospital /ID# 250955
Nagoya, Aichi-ken, Japan
Nagoya University Hospital /ID# 226746
Nagoya, Aichi-ken, Japan
Nagoya City University Hospital /ID# 238745
Nagoya, Aichi-ken, Japan
Hirosaki University Hospital /ID# 262654
Hirosaki-shi, Aomori, Japan
Misawa Municipal Misawa Hospital /ID# 229544
Misawa-shi, Aomori, Japan
Chiba University Hospital /ID# 225889
Chiba, Chiba, Japan
Japanese Red Cross Narita Hospital /ID# 261349
Narita-shi, Chiba, Japan
Matsuyama Red Cross Hospital /ID# 239387
Matsuyama, Ehime, Japan
Shikoku Central Hospital of the Mutual Aid /ID# 230273
Shikokuchūō, Ehime, Japan
Kyushu University Hospital /ID# 261351
Fukuoka, Fukuoka, Japan
Hospital of the University of Occupational and Environmental Health, Japan /ID# 255088
Kitakyushu-shi, Fukuoka, Japan
Kurume University Hospital /ID# 224112
Kurume-shi, Fukuoka, Japan
Aoyama Clinic /ID# 261942
Koriyama-shi, Fukushima, Japan
Shirakawa Kosei General Hosp. /ID# 240816
Shirakawa-shi, Fukushima, Japan
Gifu Municipal Hospital /ID# 225890
Gifu, Gifu, Japan
Machida Clinic /ID# 238744
Maebashi, Gunma, Japan
Gunma University Hospital /ID# 231700
Maebashi, Gunma, Japan
Heisei Hidaka Clinic /ID# 231758
Takasaki, Gunma, Japan
Kousei General Hospital /ID# 249395
Mihara-shi, Hiroshima, Japan
Hyogo Prefectural Amagasaki General Medical Center /ID# 239388
Amagasaki-shi, Hyōgo, Japan
Hyogo Prefectural Amagasaki General Medical Center /ID# 261350
Amagasaki-shi, Hyōgo, Japan
Fujikawa Clinic /ID# 221135
Kanzaki-gun, Hyōgo, Japan
Takano Kids Clinic /ID# 251656
Kobe, Hyōgo, Japan
University of tsukuba Hospital /ID# 267373
Tsukuba, Ibaraki, Japan
Yamada Clinic /ID# 225909
Fujisawa-shi, Kanagawa, Japan
National Hospital Organization Sagamihara National Hospital /ID# 221136
Sagamihara-shi, Kanagawa, Japan
Kawaguchi Clinic /ID# 226843
Yokohama, Kanagawa, Japan
Kumamoto Shinto General Hospital /ID# 223245
Kumamoto, Kumamoto, Japan
University Hospital Kyoto Prefectural University of Medicine /ID# 229599
Kyoto, Kyoto, Japan
Kyoto Shimogamo Hospital /ID# 233903
Kyoto, Kyoto, Japan
Okanami General Hospital /ID# 256995
Iga-shi, Mie-ken, Japan
Ise Red Cross Hospital /ID# 222018
Ise-shi, Mie-ken, Japan
Mie University Hospital /ID# 233864
Tsu, Mie-ken, Japan
Miyagi Children's Hospital /ID# 258143
Sendai, Miyagi, Japan
Aizawa Hospital /ID# 223247
Matsumoto-shi, Nagano, Japan
Nara Hospital Kinki University Faculty of Medicine, /ID# 224609
Ikoma-shi, Nara, Japan
Nakatsu Municipal Hospital /ID# 233390
Nakatsu-shi, Oita Prefecture, Japan
Watanabe Clinic /ID# 261352
Kasaoka-shi, Okayama-ken, Japan
Heartlife Hospital /ID# 249394
Nakagami-gun, Okinawa, Japan
Kitano Hospital /ID# 255150
Osaka, Osaka, Japan
Yumura Clinic /ID# 254478
Osaka, Osaka, Japan
Osaka University Hospital /ID# 256174
Suita-shi, Osaka, Japan
Saitama Medical University Hospital /ID# 258144
Iruma-gun, Saitama, Japan
Saitama Children's Medical Center /ID# 227633
Saitama-shi, Saitama, Japan
Tsukada Clinic /ID# 255152
Maibara-shi, Shiga, Japan
Tamakoshi Clinic /ID# 224113
Hamamatsu, Shizuoka, Japan
Tokyo Metropolitan Children's Medical Center /ID# 258142
Fuchu-shi, Tokyo, Japan
National Center for Child Health and Development /ID# 225293
Setagaya-ku, Tokyo, Japan
Tottori University Hospital /ID# 227634
Yonago-shi, Tottori, Japan
Ishibashi Clinic /ID# 258148
Yonezawa-shi, Yamagata, Japan
Yamaguchi University Hospital /ID# 262655
Ube-shi, Yamaguchi, Japan
Oita Cardiovascular Hospital /ID# 239725
Ōita, , Japan
Shonai Hospital /ID# 232294
Yamagata, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Clinical Study Report Synopsis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P19-620
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.